is Director of Market Development, Genetic Testing Solutions at Thermo Fisher Scientific. She leads the Communications Sub-Committee for the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Initiative, a collaborative community with participation by the U.S. Food and Drug Administration’s Center for Devices and Radiological Health, established to accelerate the development of personalized medicine practices as the standard of care and resolve shared challenges in pharmacogenetics testing. She holds a M. Phil. in Gene Therapy and Molecular Medicine from the University of Manchester (UK) and a B. S. in Bacteriology from the University of Wisconsin-Madison.